Callos Andrew's Form 4 filing
Cytokinetics Inc (CYTK) · filed Dec 5, 2025
- Accession no.
- 0001061983-25-000048
- Filed
- Dec 5, 2025
- Trade date
- Dec 5, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $3.46M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Callos AndrewCIK 0001852129 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $23.26 | +$348,900 | 65,660 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $39.13 | +$430,430 | 76,660 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseAcquired | +15,858 | $37.63 | +$596,736.54 | 92,518 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseAcquired | +10,628 | $37.63 | +$399,931.64 | 103,146 | Direct | |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −52,486 | $65.95 | −$3,461,451.7 | 50,660 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 114,000 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 36,445 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseDisposed | −15,858 | $0.00 | $0 | 15,857 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseDisposed | −10,628 | $0.00 | $0 | 2,657 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.